Polymorphism in the MRP1 Gene Related to Cystic Fibrosis
Author Information
Author(s): Nicolis Elena, Pasetto Matteo, Cigana Cristina, Pradal Ugo, Assael Baroukh M, Melotti Paola
Primary Institution: Cystic Fibrosis Center, Azienda Ospedaliera di Verona, Italy
Hypothesis
Is the GCC repeat in the MRP1 5'UTR polymorphic and does it affect promoter activity in cystic fibrosis airway epithelial cells?
Conclusion
A novel polymorphism in the MRP1 gene was identified, but its transcriptional activity does not appear to be influenced by azithromycin treatment.
Supporting Evidence
- The GCC repeat in the MRP1 gene is polymorphic, ranging from 7 to 14 triplets.
- No significant correlation was found between the number of repeats and treatment with azithromycin.
- The study suggests that the polymorphic length of the GCC repeat could be a genetic marker.
Takeaway
The study looked at a part of a gene related to cystic fibrosis and found that it can vary in length, but this doesn't change how the gene works when treated with a specific medicine.
Methodology
PCR amplification of the MRP1 5' flanking region from 36 CF patients and 100 non-CF subjects, followed by sequencing and gene reporter studies.
Limitations
The study's findings are preliminary and need confirmation in a larger population of CF subjects.
Participant Demographics
36 cystic fibrosis patients and 100 unrelated non-CF subjects.
Statistical Information
Statistical Significance
p > 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website